RealCitiesClick here to visit other RealCities sites
philly.com - The philly home page
Go to your local news sourceThe Philadelphia InquirerThe Philadelphia Daily News6ABC
 
Help Contact Us Site Index Archives Place an Ad Newspaper Subscriptions   

 Search
Search the Archives

Business
Columnists
Companies
Financial Markets
Industries
People & Events
Personal Finance
Regional Indicators
Technology

Our Site Tools

  Weather

Philadelphia4440
Doylestown3834
Atlantic City4642


  Local Events

  Yellow Pages

  Discussion Boards

  Maps & Directions
Back to Home >  Business >

Companies





MERCK NEWS  

   Examining Merck's health
Has Merck & Co. Inc., one of the world's most profitable corporations and a growth stock for years, exhausted its energies in developing breakthrough drugs and vaccines, and entered a prolonged period of mediocrity?


RELATED LINKS:
Report: Merck reported billions in revenue it never collected
Merck lowers IPO price for Medco
Merck plans to spin off Medco
Merck reports a rise in profit
Merck cited by FDA for violations
The Fool Take Merck Lurks

COMCAST NEWS  

   Comcast delays HQ space decision
The company has extended its existing Center City lease while it continues to decide whether to move or expand.


RELATED LINKS:
Comcast, AT&T; shareholders endorse merger
Comcast merger set for key votes
Uncertain signals for Comcast and AT&T;
Why investor vote won't mean much
Financial officer leaving AT&T; after merger
Comcast, AT&T; deal comes to a vote July 10

RECENT COMPANY NEWS  

   Pilots for US Airways struggle with proposal
Under the tentative deal, pilots would agree to $465 million in total salary and benefits reductions. That means a typical junior pilot would see a cut in salary from about $150,000 to $110,000. Many captains would see their annual incomes shrink from $210,000 to $155,000.


RELATED LINKS:
Acquisition to expand a Genesis unit
DuPont: Seeking a strategy
Verticalnet sells its 59 online marketplaces to an Erie firm
Teva Pharmaceutical is the top maker of generics in the U.S.
Rite Aid's profit, loss: How'd they do that?
Lockheed Martin gets a 'fantastic win' in N.J.



GLAXO NEWS  

   GlaxoSmithKline vows to seek damages over generic Augmentin threat
GlaxoSmithKline PLC, still confident it can win an appeal to keep the patent on its drug Augmentin, said Tuesday it will seek damages from any company which launches a generic version of the big-selling antibiotic.


RELATED LINKS:
AIDS care group forbids Glaxo marketing at sites
Glaxo will pay Exton company up to $270 million for drug
Glaxo lays off 90 more R&D; workers
Glaxo's post-merger profit rises 13%
An end to vaccine for Lyme disease




Shopping & Services

Find a Job, a Car,
an Apartment,
a Home, and more...
Stocks
Enter symbol/company name
 


News | Business | Sports | Entertainment | Living | Classifieds